Our Mission

PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.

Click the orange button to the right to learn more.

Search Results for: overtreatment

Ductal Carcinoma In Situ (DCIS): Is Stage 0 Breast Cancer Always Treated?

Ductal Carcinoma In Situ (DCIS): Is Stage 0 Breast Cancer Always Treated? A diagnosis of Ductal Carcinoma In-Situ (DCIS) is an alarming and potentially confusing event. DCIS is a non-invasive Stage 0 breast

Continue reading

Adjuvant Chemotherapy for Colon Cancer

I was diagnosed with stage 3 colon cancer in mid-2025. I underwent surgery to remove the tumor in my colon. I am thinking through adjuvant chemotherapy for colon cancer. Surgically removing the tumor from

Continue reading

Prostate Cancer Prevention!

Prostate cancer prevention is cheap and easy. Whereas testing for prostate cancer with conventional methods such as prostate specific antigen (PSA) testing and prostate biopsies can result in false positives

Continue reading

Mammography Pros and Cons

Yes, mammography has pros and cons. And mammography can reduce your risk of breast cancer by identifying BC at its earliest stages. At the same time, mammography causes a number of problems. More importantly,

Continue reading

Active Surveillance in DCIS

Active surveillance in DCIS is finally here. I say finally because “deintensifying treatment” has come to many other forms of cancer including prostate cancer. Years ago. When I first wrote

Continue reading

Long-Term Support for Myeloma Survivors

Long-term support for myeloma survivors is not just about screening and regular blood work. Numerous studies document both the risks and benefits from screening for all treatment-related secondary cancers.

Continue reading

How Long is Active Surveillance for Prostate Cancer?

How long should you undergo active surveillance if you have low-risk Prostate Cancer (PCa)? According to my experience compared to the study linked below, active surveillance among low-risk PCa patients

Continue reading

Rethinking “Cancer”

What do I mean when I propose the idea of “Rethinking Cancer?” I’ve spent years researching and writing about the term that I understand and have lived every aspect of it. In the case

Continue reading

Avoid DCIS Radiation?

Why would you want to avoid DCIS radiation? If you’ve been diagnosed with Ductal Carcinoma In-Situ (DCIS) you probably want to do everything possible to prevent a diagnosis of full breast cancer. For

Continue reading

Pre-cancers- DCIS, Polyps, PSA, Mole, etc.

Pre-cancers- DCIS, Polyps, PSA, Mole, etc. are all about risk. That is to say, a diagnosis of a type of pre-cancer is a diagnosis that tells you that your risk of that type of cancer has increased. The

Continue reading

Cancer OverDiagnosis- Real or Not?

Does cancer overdiagnosis actually occur? According to the ACS, cancer incidence rates were down during the pandemic. Meaning, fewer people were diagnosed with cancer in 2020 during the pandemic, than

Continue reading

Prostate Cancer- Low risk- Non-Toxic Therapies

Prostate cancer has three defining realities, in my experience. First, every man develops some prostate cancer if they live long enough. Second, conventional treatment, too often, results in difficult

Continue reading